BR112014009761A2 - composição oftálmica - Google Patents

composição oftálmica

Info

Publication number
BR112014009761A2
BR112014009761A2 BR112014009761A BR112014009761A BR112014009761A2 BR 112014009761 A2 BR112014009761 A2 BR 112014009761A2 BR 112014009761 A BR112014009761 A BR 112014009761A BR 112014009761 A BR112014009761 A BR 112014009761A BR 112014009761 A2 BR112014009761 A2 BR 112014009761A2
Authority
BR
Brazil
Prior art keywords
ophthalmic composition
ophthalmic
composition
Prior art date
Application number
BR112014009761A
Other languages
English (en)
Other versions
BR112014009761B8 (pt
BR112014009761B1 (pt
Inventor
Foschini Fulvio
Luciani Giulio
Stagni Marcello
Roy Pierre
Original Assignee
Sooft Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sooft Italia Spa filed Critical Sooft Italia Spa
Publication of BR112014009761A2 publication Critical patent/BR112014009761A2/pt
Publication of BR112014009761B1 publication Critical patent/BR112014009761B1/pt
Publication of BR112014009761B8 publication Critical patent/BR112014009761B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BR112014009761A 2011-10-25 2012-10-24 Composição de reticulação melhorada entregue por iontoforese, útil para o tratamento de ceratocone BR112014009761B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000560A ITRM20110560A1 (it) 2011-10-25 2011-10-25 Migliorata composizione di cross-linking per il trattamento del cheratocono mediante iontoforesi
ITRM2011A000560 2011-10-25
PCT/IT2012/000324 WO2013061350A1 (en) 2011-10-25 2012-10-24 Improved cross-linking composition delivered by iontophoresis, useful for the treatment of keratoconus

Publications (3)

Publication Number Publication Date
BR112014009761A2 true BR112014009761A2 (pt) 2017-04-25
BR112014009761B1 BR112014009761B1 (pt) 2022-05-24
BR112014009761B8 BR112014009761B8 (pt) 2022-09-06

Family

ID=45315962

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009761A BR112014009761B8 (pt) 2011-10-25 2012-10-24 Composição de reticulação melhorada entregue por iontoforese, útil para o tratamento de ceratocone

Country Status (16)

Country Link
US (1) US9439908B2 (pt)
EP (1) EP2770979B1 (pt)
JP (1) JP5913606B2 (pt)
KR (1) KR101837238B1 (pt)
AU (1) AU2012327916B2 (pt)
BR (1) BR112014009761B8 (pt)
CA (1) CA2851331C (pt)
EA (1) EA026703B1 (pt)
ES (1) ES2546263T3 (pt)
IL (1) IL232194A (pt)
IN (1) IN2014CN02972A (pt)
IT (1) ITRM20110560A1 (pt)
MX (1) MX342930B (pt)
PT (1) PT2770979E (pt)
RS (1) RS54139B1 (pt)
WO (1) WO2013061350A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
ES2590127T3 (es) 2011-01-12 2016-11-18 Sooft Italia S.P.A. Administración corneal de agentes de entrecruzamiento por iontoforesis para el tratamiento de queratocono y composiciones oftálmicas relacionadas
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
WO2013148896A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular treatment solutions, delivery devices and delivery augmentation methods
US9931199B2 (en) * 2014-05-05 2018-04-03 Roberto Gustavo ALBERTAZZI Methods and apparatus for treating keratoconus
CN116832158A (zh) 2015-07-21 2023-10-03 艾维德洛公司 用光敏剂治疗眼睛的系统和方法
EP3442481B1 (en) 2016-04-13 2023-06-28 Avedro, Inc. Systems for delivering drugs to an eye

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030023228A1 (en) * 2001-07-20 2003-01-30 Parkinson Thomas M. Ocular iontophoretic device and method for using the same
ITRM20070356A1 (it) * 2007-06-26 2008-12-27 Sooft Italia Srl Soluzione oculare sterile monouso e suo procedimento di produzione per il cross linking corneale del cheratocono
IT1393402B1 (it) * 2008-08-28 2012-04-20 Sooft Italia Spa Uso di enhancer eventualmente con riboflavina, nonche' relative composizioni oftalmiche per cross-linking corneale del cheratocono o di altre patologie ectasiche corneali
EP2289937A1 (en) 2009-08-24 2011-03-02 Wilfried Stücker Production of monoclonal antibodies in vitro
US20110288466A1 (en) * 2010-04-13 2011-11-24 Avedro, Inc. Systems and methods for activating cross-linking in an eye

Also Published As

Publication number Publication date
RS54139B1 (en) 2015-12-31
BR112014009761B8 (pt) 2022-09-06
CA2851331A1 (en) 2013-05-02
MX342930B (es) 2016-10-19
IN2014CN02972A (pt) 2015-07-03
KR101837238B1 (ko) 2018-03-09
ES2546263T3 (es) 2015-09-22
EA201490845A1 (ru) 2014-07-30
KR20140080553A (ko) 2014-06-30
CA2851331C (en) 2019-11-12
EP2770979B1 (en) 2015-07-08
BR112014009761B1 (pt) 2022-05-24
EA026703B1 (ru) 2017-05-31
AU2012327916B2 (en) 2016-04-21
WO2013061350A1 (en) 2013-05-02
ITRM20110560A1 (it) 2013-04-26
JP2014530904A (ja) 2014-11-20
EP2770979A1 (en) 2014-09-03
US20140303173A1 (en) 2014-10-09
AU2012327916A1 (en) 2014-05-22
MX2014004297A (es) 2014-07-24
PT2770979E (pt) 2015-10-07
US9439908B2 (en) 2016-09-13
JP5913606B2 (ja) 2016-04-27
IL232194A (en) 2016-09-29
IL232194A0 (en) 2014-06-30
CN104023706A (zh) 2014-09-03

Similar Documents

Publication Publication Date Title
BR112013022102A2 (pt) composição
DK2686017T3 (da) Oftalmisk sammensætning
DK2744810T4 (da) Tenofovir-alafenamid-hemifumarat
BR112014004395A2 (pt) composição
BR112014011444A2 (pt) óculos
DK2769050T3 (da) Propsensor
BR112014000879A2 (pt) deflegmador
BR112013033808A2 (pt) composição
DK3272861T3 (da) Alpha-galactosidase-sammensætninger
CO6960543A2 (es) 2-tiopirimidinonas
DE102011100082A8 (de) Traygreifvorrichtung
DK3141251T3 (da) Koloskopi - forberedelse
BR112014009761A2 (pt) composição oftálmica
DK2590006T3 (da) Briller
BR112014007030A2 (pt) composição
DE112011104936A5 (de) Stanzstauchniet
DE112012000958A5 (de) Handsäge
DK2717690T3 (da) Oftalmiske sammensætninger
DE112012002458A5 (de) Hydrotransformator
DE112012000819A5 (de) Gurtbandfänger
DE112012005313A5 (de) Leuchtbild
DE112012001294T8 (de) Umspritzungsverfahren
FI10522U1 (fi) Sihti
DK2726579T3 (da) Sammensætning
DE102011117169A8 (de) Absetzplattenanordnung

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B350 Update of information on the portal [chapter 15.35 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: SOOFT ITALIA SPA (IT)

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 870210121179 DE 28/12/2021, E NECESSARIO APRESENTAR A TRADUCAO JURAMENTADA DO DOCUMENTO, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/10/2012, OBSERVADAS AS CONDICOES LEGAIS

B25A Requested transfer of rights approved

Owner name: FIDIA FARMACEUTICI S.P.A. (IT)